-- 
Biondvax Poised for Biggest 2-Day Gain in 10 Months on Trials

-- B y   S u s a n   L e r n e r
-- 
2011-08-31T11:29:28Z

-- http://www.bloomberg.com/news/2011-08-31/biondvax-poised-for-biggest-2-day-gain-in-10-months-on-trials.html
Biondvax Pharmaceuticals Ltd. (BNDX)  headed
for the biggest two-day gain since October after receiving
approval to conduct a clinical trial of its universal  flu
vaccine .  The shares jumped 8.4 percent to 1.75 shekels at 2:07 p.m.
in Tel Aviv, bringing the two-day increase to 23 percent. The
stock has tumbled 36 percent this year, giving the Ness Ziona,
Israel-based company a market value of 69 million shekels ($19
million).  The company got clearance to conduct a Phase II trial of
the vaccine at hospitals in Jerusalem and Tel Aviv,  Biondvax
said  after local markets closed Aug. 29.  To contact the reporter on this story:
Susan Lerner in Jerusalem at 
 slerner2@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  